Welcome

Our goal is to map cognitive circuits to identify novel biomarkers and treatments for brain diseases that impair higher-order thought.  We focus on cortical and basal ganglia circuits defined by dopamine, which is relevant to Parkinson's disease as well as schizophrenia, ADHD, and Alzheimer’s disease. We use a combination of electroencephalography (EEG), neuronal ensemble recordings, optogenetics, brain stimulation, and behavioral neuroscience from rodents to humans.  We are working towards new knowledge, biomarkers and targeted treatments for human brain disease. 

Check out our recent publications below.